507 related articles for article (PubMed ID: 17635612)
1. Interleukin-21 differentially affects human natural killer cell subsets.
Wendt K; Wilk E; Buyny S; Schmidt RE; Jacobs R
Immunology; 2007 Dec; 122(4):486-95. PubMed ID: 17635612
[TBL] [Abstract][Full Text] [Related]
2. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
3. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
Voss SD; Daley J; Ritz J; Robertson MJ
J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418
[TBL] [Abstract][Full Text] [Related]
4. Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures.
Fukui A; Kwak-Kim J; Ntrivalas E; Gilman-Sachs A; Lee SK; Beaman K
Fertil Steril; 2008 Jan; 89(1):157-65. PubMed ID: 17482605
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
[TBL] [Abstract][Full Text] [Related]
6. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
[TBL] [Abstract][Full Text] [Related]
7. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
Dadmarz R; Bockstoce DC; Golub SH
Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
[TBL] [Abstract][Full Text] [Related]
9. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
10. Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population.
Marquardt N; Wilk E; Pokoyski C; Schmidt RE; Jacobs R
Eur J Immunol; 2010 May; 40(5):1428-39. PubMed ID: 20186880
[TBL] [Abstract][Full Text] [Related]
11. Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.
Riley CH; Hansen M; Brimnes MK; Hasselbalch HC; Bjerrum OW; Straten PT; Svane IM; Jensen MK
Eur J Haematol; 2015 Mar; 94(3):227-34. PubMed ID: 25082025
[TBL] [Abstract][Full Text] [Related]
12. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
13. Invasive Surgery Impairs the Regulatory Function of Human CD56 bright Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis.
Reinhardt R; Pohlmann S; Kleinertz H; Hepner-Schefczyk M; Paul A; Flohé SB
PLoS One; 2015; 10(6):e0130155. PubMed ID: 26090673
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.
Keating SE; Zaiatz-Bittencourt V; Loftus RM; Keane C; Brennan K; Finlay DK; Gardiner CM
J Immunol; 2016 Mar; 196(6):2552-60. PubMed ID: 26873994
[TBL] [Abstract][Full Text] [Related]
15. CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.
Rutjens E; Mazza S; Biassoni R; Koopman G; Ugolotti E; Fogli M; Dubbes R; Costa P; Mingari MC; Greenwood EJ; Moretta L; De Maria A; Heeney JL
Eur J Immunol; 2010 May; 40(5):1440-50. PubMed ID: 20306468
[TBL] [Abstract][Full Text] [Related]
16. CD16- CD56+ natural killer cells after bone marrow transplantation.
Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
[TBL] [Abstract][Full Text] [Related]
17. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G
J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680
[TBL] [Abstract][Full Text] [Related]
18. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
[TBL] [Abstract][Full Text] [Related]
19. Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56(dim) natural killer cells.
Zheng X; Wang Y; Wei H; Ling B; Sun R; Tian Z
Mol Immunol; 2008 May; 45(9):2559-69. PubMed ID: 18295891
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Huth TK; Staines D; Marshall-Gradisnik S
J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
